Autoimmune meningoencephalitis in a melanoma patient treated with ipilimumab.
Divisions of Hematology & Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Jennifer H
JH
Choe
Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Brian J
BJ
Andonian
Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.
Grace J
GJ
Kim
Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
April Ks
AK
Salama
D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects*; D001327:Autoimmune Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D000074324:Ipilimumab / Q000009:adverse effects*; D008545:Melanoma / Q000188:drug therapy*; D008590:Meningoencephalitis / Q000139:chemically induced*; D008875:Middle Aged
D000074322:Antineoplastic Agents, Immunological; D000074324:Ipilimumab
IVIG; immune-related adverse events; ipilimumab; melanoma; radiation therapy